Arata H, Takashima H, Hirano R, Tomimitsu H, Machigashira K, Izumi K, Kikuno M, Ng A R, Umehara F, Arisato T, Ohkubo R, Nakabeppu Y, Nakajo M, Osame M, Arimura K
Department of Neurology and Geriatrics, Kagoshima University School of Medicine, Kagoshima City, Japan.
Neurology. 2006 Jun 13;66(11):1672-8. doi: 10.1212/01.wnl.0000218211.85675.18.
To determine the clinical and radiologic features of Gerstmann-Sträussler-Scheinker syndrome caused by Pro102Leu mutation in PRNP (GSS102).
The authors report 11 patients (nine families) with clinically and radiologically diagnosed GSS102.
All patients showed mild gait disturbance, dysesthesia and hyporeflexia of the lower legs, and truncal ataxia, and 9 of 11 patients showed proximal leg muscle weakness during the early stage of the disease. Dementia was not a main symptom during the early stage. Brain MRI and EEG abnormalities were not prominent initially. SPECT (N-isopropyl-p-[(123)I]iodoamphetamine) analyzed by the three-dimensional stereotactic surface projection (SSP) method detected abnormalities in five patients early during the course of the illness. SPECT findings showed diffusely decreased cerebral blood flow, demonstrated by a mosaic pattern, with the lowest perfusion noted in the occipital lobes. In contrast, blood flow to the cerebellum was preserved. These studies suggested sites of pathology in GSS102, with the main lesions probably located in the cerebrum and the spinal cord (posterior horn and spinocerebellar tract) instead of the cerebellum.
Key features for early diagnosis of Gerstmann-Sträussler-Scheinker syndrome caused by Pro102Leu mutation in PRNP (GSS102) are truncal ataxia, dysesthesia and hyporeflexia of the lower legs, and mild dysarthria. Normal cerebellar MRI and abnormal cerebral SPECT findings are characters of early GSS102.
确定由PRNP基因Pro102Leu突变所致的格斯特曼-施特劳斯勒-谢inker综合征(GSS102)的临床和影像学特征。
作者报告了11例经临床和影像学诊断为GSS102的患者(9个家系)。
所有患者均表现为轻度步态障碍、小腿感觉异常和反射减退,以及躯干共济失调,11例患者中有9例在疾病早期出现近端腿部肌肉无力。痴呆在疾病早期不是主要症状。脑MRI和脑电图异常最初并不突出。通过三维立体定向表面投影(SSP)方法分析的单光子发射计算机断层扫描(SPECT,N-异丙基-p-[(123)I]碘安非他明)在5例患者病程早期检测到异常。SPECT结果显示脑血流弥漫性减少,呈镶嵌样表现,枕叶灌注最低。相比之下,小脑血流得以保留。这些研究提示了GSS102的病变部位,主要病变可能位于大脑和脊髓(后角和脊髓小脑束)而非小脑。
PRNP基因Pro102Leu突变所致的格斯特曼-施特劳斯勒-谢inker综合征(GSS102)早期诊断的关键特征是躯干共济失调、小腿感觉异常和反射减退,以及轻度构音障碍。小脑MRI正常而大脑SPECT异常是GSS102早期的特征。